J W Yaxley1, J Dagher2,3, B Delahunt4, L Egevad5, J Srigley6, H Samaratunga2. 1. Wesley Urology Clinic, Brisbane, QLD, Australia. john@wesleyurologyclinic.com.au. 2. Aquesta Uro-pathology, University of Queensland, Brisbane, QLD, Australia. 3. Rennes University Hospital, University of Rennes, Rennes, France. 4. Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, Wellington, New Zealand. 5. Department of Oncology Pathology, Karolineska Institute, Stockholm, Sweden. 6. Trilium Health Partners and University Toronto, Mississauga, ON, Canada.
Abstract
BACKGROUND: Performing an extended pelvic lymph node dissection (PLND) on all men with intermediate- and high-risk prostate cancer at the time of a radical prostatectomy (RP) remains controversial. The majority of patients PLND histology is benign, and the long-term cancer-free progression in men with positive lymph node metastasis is low. The objective is to investigate the probability of long-term biochemical freedom from recurrent disease (bNED) in men with lymph node metastasis identified at the time of radical prostatectomy (RP). SUBJECTS AND METHODS: A retrospective review of the pathology of 1184 pelvic lymph node dissections performed at the time of a radical prostatectomy by multiple surgeons referred to a single uro-pathology laboratory between 2008 and 2014 identified 61 men with node-positive prostate cancer. Of the men with positive nodes, 24 had a standard PLND and 37 an extended PLND (ePLND). bNED was defined as a post-operative serum PSA < 0.2 ng/ml. RESULTS: The median follow-up is 4 years (2-8). The median lymph node count was 7 (range 2-16) for PLND and 22 (range 6-46) for the ePLND. A single lymph node metastasis was identified in 56% of the 61 men. Only 10% of men with a positive lymph node metastasis remained free of biochemical recurrence of disease, and only 5% had undetectable serum PSA. There was no difference in bNED outcome between a PLND and ePLND. The number of men needed to be treated with a PLND at the time of RP (NNT) to result in an undetectable post-operative PSA at a median follow-up of 4 years is 395. CONCLUSIONS: In men with lymph node metastasis, the probability of long-term bNED is low and the NNT for cure is high. With emerging improved radiological imaging techniques increasing the detection of lymph node metastasis outside the extended lymph node dissection templates, more scientific investigation is required to evaluate which men will benefit from a PLND and which men can avoid an unnecessary PLND procedure.
BACKGROUND: Performing an extended pelvic lymph node dissection (PLND) on all men with intermediate- and high-risk prostate cancer at the time of a radical prostatectomy (RP) remains controversial. The majority of patients PLND histology is benign, and the long-term cancer-free progression in men with positive lymph node metastasis is low. The objective is to investigate the probability of long-term biochemical freedom from recurrent disease (bNED) in men with lymph node metastasis identified at the time of radical prostatectomy (RP). SUBJECTS AND METHODS: A retrospective review of the pathology of 1184 pelvic lymph node dissections performed at the time of a radical prostatectomy by multiple surgeons referred to a single uro-pathology laboratory between 2008 and 2014 identified 61 men with node-positive prostate cancer. Of the men with positive nodes, 24 had a standard PLND and 37 an extended PLND (ePLND). bNED was defined as a post-operative serum PSA < 0.2 ng/ml. RESULTS: The median follow-up is 4 years (2-8). The median lymph node count was 7 (range 2-16) for PLND and 22 (range 6-46) for the ePLND. A single lymph node metastasis was identified in 56% of the 61 men. Only 10% of men with a positive lymph node metastasis remained free of biochemical recurrence of disease, and only 5% had undetectable serum PSA. There was no difference in bNED outcome between a PLND and ePLND. The number of men needed to be treated with a PLND at the time of RP (NNT) to result in an undetectable post-operative PSA at a median follow-up of 4 years is 395. CONCLUSIONS: In men with lymph node metastasis, the probability of long-term bNED is low and the NNT for cure is high. With emerging improved radiological imaging techniques increasing the detection of lymph node metastasis outside the extended lymph node dissection templates, more scientific investigation is required to evaluate which men will benefit from a PLND and which men can avoid an unnecessary PLND procedure.
Authors: Esther M K Wit; Cenk Acar; Nikolaos Grivas; Cathy Yuan; Simon Horenblas; Fredrik Liedberg; Renato A Valdes Olmos; Fijs W B van Leeuwen; Nynke S van den Berg; Alexander Winter; Friedhelm Wawroschek; Stephan Hruby; Günter Janetschek; Sergi Vidal-Sicart; Steven MacLennan; Thomas B Lam; Henk G van der Poel Journal: Eur Urol Date: 2016-09-14 Impact factor: 20.096
Authors: Phillip M Pierorazio; Michael A Gorin; Ashley E Ross; Zhaoyong Feng; Bruce J Trock; Edward M Schaeffer; Misop Han; Jonathan I Epstein; Alan W Partin; Patrick C Walsh; Trinity J Bivalacqua Journal: Prostate Date: 2013-09-09 Impact factor: 4.104
Authors: John W Yaxley; Geoffrey D Coughlin; Suzanne K Chambers; Stefano Occhipinti; Hema Samaratunga; Leah Zajdlewicz; Nigel Dunglison; Rob Carter; Scott Williams; Diane J Payton; Joanna Perry-Keene; Martin F Lavin; Robert A Gardiner Journal: Lancet Date: 2016-07-26 Impact factor: 79.321
Authors: Alberto Briganti; Felix K-H Chun; Andrea Salonia; Nazareno Suardi; Andrea Gallina; Luigi Filippo Da Pozzo; Marco Roscigno; Giuseppe Zanni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz Journal: Eur Urol Date: 2006-08-31 Impact factor: 20.096
Authors: Lars Budäus; Sami-Ramzi Leyh-Bannurah; Georg Salomon; Uwe Michl; Hans Heinzer; Hartwig Huland; Markus Graefen; Thomas Steuber; Clemens Rosenbaum Journal: Eur Urol Date: 2015-06-25 Impact factor: 20.096
Authors: Greta Meredith; David Wong; John Yaxley; Geoff Coughlin; Les Thompson; Boon Kua; Troy Gianduzzo Journal: BJU Int Date: 2016-09-23 Impact factor: 5.588
Authors: Georgios Gakis; Stephen A Boorjian; Alberto Briganti; Steven Joniau; Guram Karazanashvili; R Jeffrey Karnes; Agostino Mattei; Shahrokh F Shariat; Arnulf Stenzl; Manfred Wirth; Christian G Stief Journal: Eur Urol Date: 2013-05-22 Impact factor: 20.096